XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Conversion of Common Stock
Conversion of Convertible Preferred Stock and Previously Authorized Common Stock
Class A
Class B
Convertible Preferred Stock
Convertible Preferred Stock
Conversion of Convertible Preferred Stock and Previously Authorized Common Stock
Common Stock
Common Stock
Conversion of Convertible Preferred Stock and Previously Authorized Common Stock
Common Stock
Class A
Common Stock
Class A
Conversion of Common Stock
Common Stock
Class B
Common Stock
Class B
Conversion of Common Stock
Common Stock
Class B
Conversion of Convertible Preferred Stock and Previously Authorized Common Stock
Additional Paid In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020               42,279,000   0   0          
Beginning balance (in shares) at Dec. 31, 2020           114,164,600                      
Beginning balance at Dec. 31, 2020 $ (3,159)         $ 0   $ 0   $ 0   $ 0     $ 158,483 $ (339) $ (161,303)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Issuance of common stock for exercise of stock options (in shares)               274,720       2,899,008          
Issuance of common stock for exercise of stock options 3,435                           3,435    
Issuance of common stock for business combinations (in shares)               1,245,440                  
Issuance of common stock for business combinations 24,675                           24,675    
Repurchase of common stock (in shares)               (97,600)                  
Repurchase of common stock (181)                           (181)    
Issuance of common stock upon settlement of restricted stock units (in shares)                   954,297              
Conversion of stock to Common stock (in shares)             (114,164,600)   (43,701,560)   21,128,743   (21,128,743) 157,866,160      
Conversion of stock to common stock     $ 2                     $ 2      
Issuance of common stock in connection with initial public offering, net of underwriting discounts and issuance costs (in shares)                   10,425,000              
Issuance of common stock in connection with initial public offering, net of underwriting discounts and issuance costs 153,796                           153,796    
Taxes paid related to net share settlement of equity awards (in shares)                   (423,865)   (362,741)          
Taxes paid related to net share settlement of equity awards (11,892)                           (11,892)    
Stock compensation expense 22,377                           22,377    
Other comprehensive loss (705)                             (705)  
Net income (loss) (16,243)                               (16,243)
Ending balance (in shares) at Sep. 30, 2021               0   32,084,175   139,273,684          
Ending balance (in shares) at Sep. 30, 2021           0                      
Ending balance at Sep. 30, 2021 172,105         $ 0   $ 0   $ 0   $ 2     350,693 (1,044) (177,546)
Beginning balance (in shares) at Jun. 30, 2021                   11,709,402   157,697,645          
Beginning balance at Jun. 30, 2021 174,906                 $ 0   $ 2     351,124 (254) (175,966)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Issuance of common stock for exercise of stock options (in shares)                       2,309,071          
Issuance of common stock for exercise of stock options 2,483                           2,483    
Issuance of common stock upon settlement of restricted stock units (in shares)                   4,482              
Conversion of stock to Common stock (in shares)                     20,370,291   (20,370,291)        
Taxes paid related to net share settlement of equity awards (in shares)                       (362,741)          
Taxes paid related to net share settlement of equity awards (5,110)                           (5,110)    
Stock compensation expense 2,196                           2,196    
Other comprehensive loss (790)                             (790)  
Net income (loss) (1,580)                               (1,580)
Ending balance (in shares) at Sep. 30, 2021               0   32,084,175   139,273,684          
Ending balance (in shares) at Sep. 30, 2021           0                      
Ending balance at Sep. 30, 2021 $ 172,105         $ 0   $ 0   $ 0   $ 2     350,693 (1,044) (177,546)
Beginning balance (in shares) at Dec. 31, 2021       66,335,930 107,936,779         66,335,930   107,936,779          
Beginning balance (in shares) at Dec. 31, 2021 0                                
Beginning balance at Dec. 31, 2021 $ 217,267                 $ 1   $ 2     391,803 (1,391) (173,148)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Issuance of common stock for exercise of stock options (in shares) 1,303,530                     1,303,530          
Issuance of common stock for exercise of stock options $ 3,235                           3,235    
Issuance of common stock under the employee stock purchase plan (in shares)                   193,595              
Issuance of common stock under the employee stock purchase plan 2,932                           2,932    
Issuance of common stock upon settlement of restricted stock units (in shares)                   431,556              
Conversion of stock to Common stock (in shares)                     18,787,775   (18,787,775)        
Conversion of stock to common stock   $ (1)                     $ (1)        
Taxes paid related to net share settlement of equity awards (in shares)                   (147,053)              
Taxes paid related to net share settlement of equity awards (2,682)                           (2,682)    
Stock compensation expense 17,918                           17,918    
Other comprehensive loss (2,707)                             (2,707)  
Net income (loss) $ 11,223                               11,223
Ending balance (in shares) at Sep. 30, 2022       85,601,803 90,452,534         85,601,803   90,452,534          
Ending balance (in shares) at Sep. 30, 2022 0                                
Ending balance at Sep. 30, 2022 $ 247,185                 $ 1   $ 1     413,206 (4,098) (161,925)
Beginning balance (in shares) at Jun. 30, 2022                   78,178,186   97,492,186          
Beginning balance at Jun. 30, 2022 236,520                 $ 1   $ 1     407,620 (2,662) (168,440)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Issuance of common stock for exercise of stock options (in shares)                       340,526          
Issuance of common stock for exercise of stock options 1,013                           1,013    
Issuance of common stock upon settlement of restricted stock units (in shares)                   77,113              
Conversion of stock to Common stock (in shares)                     7,380,178   (7,380,178)        
Taxes paid related to net share settlement of equity awards (in shares)                   (33,674)              
Taxes paid related to net share settlement of equity awards (697)                           (697)    
Stock compensation expense 5,270                           5,270    
Other comprehensive loss (1,436)                             (1,436)  
Net income (loss) $ 6,515                               6,515
Ending balance (in shares) at Sep. 30, 2022       85,601,803 90,452,534         85,601,803   90,452,534          
Ending balance (in shares) at Sep. 30, 2022 0                                
Ending balance at Sep. 30, 2022 $ 247,185                 $ 1   $ 1     $ 413,206 $ (4,098) $ (161,925)